Response of FDG avid pelvic bone marrow to concurrent chemoradiation for anal cancer
<p><strong>Background and Purpose:</strong> To determine if suppression of active bone marrow, as defined on FDG PETCT, is seen in on-treatment imaging of anal cancer patients receiving concurrent chemoradiation.</p> <p><strong>Methods and Materials:</strong>...
Auteurs principaux: | , , , , , , , , , |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Elsevier
2019
|